Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Care Coordination, Equity Can Eliminate Disparities for Nonwhite Patients with DLBCL

Key clinical point: A care coordination program can level the playing field for nonwhite patients with diffuse large B-cell lymphoma (DLBCL).

Major finding: Overall survival for patients with relapsed/refractory disease was 74% for whites and 81% for nonwhites.

Study details: Retrospective review of data on 155 white and 41 nonwhite patients with de novo DLBCL.

Disclosures: The study was internally funded. Dr. Ghosh reported consulting fees, research funding, speakers bureau activity, and/or honoraria from multiple companies.


Hu B et al. ASH 2019. Abstract 425.